Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2005-02-22
2005-02-22
Huang, Evelyn Mei (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C514S249000, C514S259100, C514S259300, C514S259310, C514S267000, C514S294000, C514S299000, C514S300000, C514S303000, C514S305000, C544S281000, C544S282000, C544S349000, C544S350000, C544S252000, C544S256000, C546S112000, C546S118000, C546S121000, C546S133000, C546S135000, C546S094000
Reexamination Certificate
active
06858613
ABSTRACT:
The invention provides compounds of Formula I:These compounds may be in the form of pharmaceutical salts or compositions, may be in pure enantiomeric form or racemic mixtures, and are useful in pharmaceuticals to treat conditions or diseases in which α7 is known to be involved.
REFERENCES:
patent: 4605652 (1986-08-01), Welstead
patent: 4612319 (1986-09-01), King
patent: 4721720 (1988-01-01), Wootton
patent: 4797406 (1989-01-01), Richardson
patent: 4798829 (1989-01-01), King
patent: 4803199 (1989-02-01), Donatsch
patent: 4822795 (1989-04-01), King
patent: 4835162 (1989-05-01), Abood
patent: 4845092 (1989-07-01), Sanger
patent: 4882327 (1989-11-01), King
patent: 4888353 (1989-12-01), Lednicer
patent: 4910193 (1990-03-01), Buchheit
patent: 4920127 (1990-04-01), King
patent: 4920219 (1990-04-01), Pelletier
patent: 4921982 (1990-05-01), Cohen
patent: 4933445 (1990-06-01), Pelletier
patent: 4935511 (1990-06-01), Youssefyeh
patent: 4937247 (1990-06-01), King
patent: 4973594 (1990-11-01), Tyers
patent: 4983600 (1991-01-01), Ward
patent: 4985437 (1991-01-01), Tyers
patent: 5001133 (1991-03-01), Richardson
patent: 5039680 (1991-08-01), Imperato
patent: 5183822 (1993-02-01), Van Wijngaarden
patent: 5260303 (1993-11-01), Becker
patent: 5322951 (1994-06-01), King
patent: 5342845 (1994-08-01), Chokai
patent: 5352685 (1994-10-01), Maruyama
patent: 5362740 (1994-11-01), Bedeschi
patent: 5434161 (1995-07-01), Becker
patent: 5543426 (1996-08-01), Dixon
patent: 5561149 (1996-10-01), Azriz
patent: 5576434 (1996-11-01), Robinson, III
patent: 5599937 (1997-02-01), Glas
patent: 5750536 (1998-05-01), Mantovanini
patent: 5977144 (1999-11-01), Meyer
patent: 5998429 (1999-12-01), Macor
patent: 6054464 (2000-04-01), Macor
patent: 6060473 (2000-05-01), Shen
patent: 6117889 (2000-09-01), Shen
patent: 6255490 (2001-07-01), Shen
patent: 6441049 (2002-08-01), Reitz
patent: 20020016334 (2002-02-01), Coa
patent: 3810552 (1998-03-01), None
patent: 0030254 (1980-08-01), None
patent: 0635508 (1992-04-01), None
patent: 483 836 (1992-05-01), None
patent: 496 064 (1992-07-01), None
patent: 512 350 (1992-11-01), None
patent: WO 9014347 (1990-11-01), None
patent: WO 9109593 (1991-07-01), None
patent: WO 9117161 (1991-11-01), None
patent: WO 9210494 (1992-06-01), None
patent: WO 9306108 (1993-04-01), None
patent: WO 9309116 (1993-05-01), None
patent: WO 9504742 (1995-02-01), None
patent: WO 9527490 (1995-10-01), None
patent: WO 9633186 (1996-10-01), None
patent: WO 9735860 (1997-10-01), None
patent: WO 9854181 (1998-12-01), None
patent: WO 9920633 (1999-04-01), None
patent: WO 0073431 (2000-12-01), None
patent: WO 0129034 (2001-04-01), None
patent: WO 0136417 (2001-05-01), None
patent: WO 0160821 (2001-08-01), None
patent: WO 0176576 (2001-10-01), None
patent: WO 02085901 (2002-10-01), None
patent: WO 02100858 (2002-12-01), None
patent: WO03055878 (2003-07-01), None
Bencherif, M.,Journal of Pharmacology and Experiemental Therapeutics, 03(1998) 886-896.
Cooper and Millar,J. Neurochem, 1997, 68(5), pp. 2140-2151.
Eisele et al.,Chimaeric nicotinic-serotonergic receptor combines distinct ligand binding and channel specificities, Nature, 366(6454), pp. 479-483, 1993.
Hansen, et al,Bioorg. &Med. Chem. Lett 4(1994) 695-698.
Holladay, et al.Journal of Medicinal Chemistry, vol. 40, No. 26 , 4169-4194, XP-002124847.
Kem, WR,Behavioral Brain Res., 113 (2000) 169-181.
Macor, J. et al,Bioorg. &Med. Chem. Lett. 11 (2001) 319-321.
Orjales, A., et al,Eur. J. Med. Chem., 34(1999) 415-422.
Sabb, et al,Bioorg. &Med. Chem. Lett 9(1999) 1895-1900.
Acker Brad A.
Groppi, Jr. Vincent E.
Jacobsen Eric Jon
Piotrowski David W.
Rogers Bruce N.
Dorigo Andrea E.
Huang Evelyn Mei
Ling Lorriane B.
Pfizer Inc.
Richardson Peter C.
LandOfFree
Fused bicyclic-N-bridged-heteroaromatic carboxamides for the... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fused bicyclic-N-bridged-heteroaromatic carboxamides for the..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fused bicyclic-N-bridged-heteroaromatic carboxamides for the... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3455803